Jeffrey B. "Jeff" Coopersmith

Jeffrey B. Coopersmith is a veteran trial lawyer and former federal prosecutor with a Pacific Northwest, California, and national practice focusing on white collar criminal matters and parallel civil and regulatory proceedings, federal and state False Claims Act investigations and litigation, internal investigations for private and public entities, and complex commercial litigation. During his eight-year tenure as an Assistant United States Attorney, Jeff handled some of the largest and most challenging white collar criminal cases in the Western District of Washington. He held the position of Deputy Supervisor of Complex Crimes and Coordinator for Corporate and Securities Fraud, successfully leading the prosecution of 12 defendants in one of the largest securities fraud cases in Washington state history as well as many other complex white collar cases. He received several awards for his work as a federal prosecutor, including the inaugural Thomas C. Wales award, the highest honor in the office. Jeff is ranked in Chambers USA Band 1 for White Collar Criminal Defense in Washington. He is widely recognized for his outstanding achievements in handling a diverse range of legal matters representing companies and individuals in connection with investigations and criminal, civil, and administrative enforcement proceedings in the areas of healthcare, securities, insurance, FCPA, antitrust, tax, banking, legal ethics, and others. Jeff also frequently represents companies and individuals in federal and state False Claims Act litigation, including in matters involving healthcare and government contracting claims. His internal investigation work includes representing board committees, companies, municipalities, and corporate officers. Jeff’s complex matters often involve parallel criminal, civil, and/or regulatory proceedings. Jeff’s background in criminal and civil litigation allows him to provide comprehensive representation in these matters. Jeff has handled cases arising out of the 2008 financial crisis, the stock options backdating scandal, the government’s focus on healthcare fraud, cryptocurrency enforcement proceedings, the downfall of Theranos, and many others.